Catch up on the latest news about what we’ve been up to and what’s happening at Haapaniemi Lab, including new job openings, research updates, new publications and team events.
We are working on editing defective genes with CRISPR, a method we hope can cure all primary immunodeficiency diseases in the future. The technique we are developing can also be used to treat cancer.
Thapelo is back with us to work on his master’s thesis, and Carolina has joined the team as our new PhD student. Welcome!
Our group leader was interviewed in Apollon, the award-winning magazine published by the University of Oslo.
We’ve received a 19.9 million NOK funding from KLINBEFORSK for developing CRISPR-Cas9 gene therapy for STAT1 Gain-of-Function disease.
We are very proud to be part of Precision Immunotherapy Alliance “PRIMA”, a new Center of Excellence recently founded by The Research Council of Norway!
Pavel Kopcil attended the eight annual meeting on Genome engineering: CRISPR Frontiers at Cold Spring Harbor Laboratory in New York.
We’ve won the European Genomics Grant from Standard BioTools! As the prize we will have the C1 system from Standard BioTools™ installed in our laboratory.
On 22nd of June, Jacob defended his master thesis “In vivo and in vitro strategies to study precise gene editing using CRISPR-Cas9”.
Aftenposten run a focused life science collection. Our laboratory was featured as representatives of NCMM in an article about new therapies for serious diseases in children.